ResearcherNanyang Technological UniversityActive in the last 2 years
Feng Yin
Matched on ORCID iD 0000-0001-7407-9047; OpenAlex author ID A5101648965. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2015: 2 papers · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 6
- Erratum: Functionalized MoS2 Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy: Erratum. Co-author DOI 10.7150/ntno.105822↗
- Functionalized MoS2 Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy. Co-author DOI 10.7150/ntno.27308↗
- Biodegradable nanoparticles as siRNA carriers for in vivo gene silencing and pancreatic cancer therapy. Co-author DOI 10.1039/c6tb03116a↗
- SiRNA Delivery with PEGylated Graphene Oxide Nanosheets for Combined Photothermal and Genetherapy for Pancreatic Cancer. Co-author DOI 10.7150/thno.17841↗
- RNAi-based therapeutic nanostrategy: IL-8 gene silencing in pancreatic cancer cells using gold nanorods delivery vehicles. Co-author DOI 10.1088/0957-4484/26/36/365101↗
- A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA. Co-author DOI 10.7150/thno.11335↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ken‐Tye Yong · 6 shared papers, 2015–2024 · strength 0.53
- Paper Erratum: Functionalized MoS2 Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy: Erratum. DOI 10.7150/ntno.105822↗
- Paper Functionalized MoS2 Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy. DOI 10.7150/ntno.27308↗
- Paper SiRNA Delivery with PEGylated Graphene Oxide Nanosheets for Combined Photothermal and Genetherapy for Pancreatic Cancer. DOI 10.7150/thno.17841↗
- Nishtha Panwar · 3 shared papers, 2015–2024 · strength 0.36
- Paper Erratum: Functionalized MoS2 Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy: Erratum. DOI 10.7150/ntno.105822↗
- Paper Functionalized MoS2 Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy. DOI 10.7150/ntno.27308↗
- Paper RNAi-based therapeutic nanostrategy: IL-8 gene silencing in pancreatic cancer cells using gold nanorods delivery vehicl… DOI 10.1088/0957-4484/26/36/365101↗
- Tommy Anderson · 2 shared papers, 2018–2024 · strength 0.30
- Chengbin Yang · 3 shared papers, 2015–2017 · strength 0.16
- Paper Biodegradable nanoparticles as siRNA carriers for in vivo gene silencing and pancreatic cancer therapy. DOI 10.1039/c6tb03116a↗
- Paper RNAi-based therapeutic nanostrategy: IL-8 gene silencing in pancreatic cancer cells using gold nanorods delivery vehicl… DOI 10.1088/0957-4484/26/36/365101↗
- Paper A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubic… DOI 10.7150/thno.11335↗
- Guimiao Lin · 2 shared papers, 2015–2017 · strength 0.10
- Zigang Li · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.